Crombez Eric sold RARE
May 5, 2026 · Form 4 insider transaction
Crombez Eric sold 344 shares of Ultragenyx Pharmaceutical Inc. at $24.96 per share, a transaction worth $8.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
344
Price
$24.96
Total value
$8.6K
InsiderCrombez Eric
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 5, 2026
Filing dateMay 6, 2026
Shares owned after111,189
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares sold to pay required tax withholdings due to the vesting of RSUs.; Includes 558 shares acquired under the Company's Amended and Restated Employee Stock Purchase Plan on April 30, 2026; Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.